Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
20.07
-1.02 (-4.84%)
At close: Oct 23, 2026, 4:00 PM EDT
20.03
-0.04 (-0.20%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Tectonic Therapeutic Market Cap
Tectonic Therapeutic has a market cap or net worth of $392.36 million as of October 23, 2026. It is the 16,255th most valuable company in the world and the 2,914th biggest in the United States. Its market cap has increased by 18.46% in one year.
Market Cap
392.36M
Enterprise Value
169.69M
1-Year Change
18.46%
Global Rank
Country Rank
#2,914 United States
Category
ChartMarket Cap Chart
Since June 21, 2024, Tectonic Therapeutic's market cap has increased from $250.63M to $392.36M, an increase of 56.55%. That is a compound annual growth rate of 21.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 392.36M | 0.50% |
| Dec 31, 2025 | 390.42M | -42.68% |
| Dec 31, 2024 | 681.13M | 171.77% |
| Jun 21, 2024 | 250.63M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Allogene Therapeutics | 445.68M |
| AgomAb Therapeutics NV | 444.96M |
| Eikon Therapeutics | 444.15M |
| ProKidney | 436.86M |
| TRex Bio | 430.75M |
| Altimmune | 427.94M |
| ARS Pharmaceuticals | 423.65M |
| Autolus Therapeutics | 419.21M |